FERRI, Clodoveo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 55.840
EU - Europa 27.719
AS - Asia 22.396
SA - Sud America 2.689
AF - Africa 435
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 40
Totale 109.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 55.100
GB - Regno Unito 10.000
IT - Italia 7.460
SG - Singapore 6.712
CN - Cina 6.297
HK - Hong Kong 3.012
BR - Brasile 2.070
SE - Svezia 1.969
VN - Vietnam 1.765
DE - Germania 1.623
FI - Finlandia 1.492
UA - Ucraina 1.436
TR - Turchia 1.418
FR - Francia 1.267
RU - Federazione Russa 852
KR - Corea 639
IN - India 560
BG - Bulgaria 504
BD - Bangladesh 489
CA - Canada 345
ID - Indonesia 281
NL - Olanda 246
MX - Messico 226
JP - Giappone 224
AR - Argentina 216
IE - Irlanda 203
ZA - Sudafrica 157
IQ - Iraq 137
AE - Emirati Arabi Uniti 117
PL - Polonia 116
EC - Ecuador 107
PK - Pakistan 106
MY - Malesia 86
ES - Italia 83
CO - Colombia 75
CL - Cile 71
BE - Belgio 68
BZ - Belize 67
IR - Iran 67
SA - Arabia Saudita 61
MA - Marocco 57
RO - Romania 57
PH - Filippine 56
AT - Austria 53
UZ - Uzbekistan 53
EG - Egitto 51
VE - Venezuela 49
LT - Lituania 43
TH - Thailandia 38
TN - Tunisia 38
AU - Australia 37
NP - Nepal 37
CH - Svizzera 36
TW - Taiwan 36
JO - Giordania 35
EU - Europa 34
PY - Paraguay 33
PE - Perù 28
AZ - Azerbaigian 27
KE - Kenya 26
IL - Israele 25
PT - Portogallo 25
CZ - Repubblica Ceca 24
OM - Oman 21
BO - Bolivia 19
UY - Uruguay 19
DZ - Algeria 17
HU - Ungheria 17
BY - Bielorussia 15
DO - Repubblica Dominicana 15
GR - Grecia 15
KG - Kirghizistan 15
AL - Albania 14
JM - Giamaica 14
KZ - Kazakistan 14
ET - Etiopia 13
LV - Lettonia 13
PA - Panama 13
PS - Palestinian Territory 13
TT - Trinidad e Tobago 13
DK - Danimarca 12
NO - Norvegia 12
CR - Costa Rica 11
SN - Senegal 11
HN - Honduras 10
CI - Costa d'Avorio 9
LU - Lussemburgo 9
RS - Serbia 9
SY - Repubblica araba siriana 9
CY - Cipro 8
MD - Moldavia 8
ML - Mali 7
NG - Nigeria 7
SK - Slovacchia (Repubblica Slovacca) 7
BA - Bosnia-Erzegovina 6
GE - Georgia 6
LB - Libano 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
Totale 109.047
Salva come PNG Salva come JPEG
Città #
Southend 7.726
Fairfield 5.009
Singapore 4.434
Ashburn 4.240
Santa Clara 4.124
Woodbridge 3.480
Hong Kong 2.973
Jacksonville 2.762
Houston 2.682
Chandler 2.065
Hefei 1.956
Ann Arbor 1.930
Seattle 1.799
Wilmington 1.788
Chicago 1.765
Dearborn 1.675
Cambridge 1.605
San Jose 1.453
Los Angeles 1.452
London 1.162
Beijing 1.118
Nyköping 1.083
Helsinki 1.033
Council Bluffs 971
The Dalles 853
Izmir 824
Salt Lake City 772
Milan 649
Modena 625
New York 584
Seoul 580
Ho Chi Minh City 549
San Diego 528
Princeton 523
Sofia 491
Rome 469
Eugene 448
Hanoi 441
Lauterbourg 399
Tampa 377
Elk Grove Village 336
Dallas 322
Buffalo 309
Des Moines 260
Columbus 255
Moscow 250
Shanghai 221
Atlanta 219
Jakarta 202
São Paulo 194
Redwood City 180
Frankfurt am Main 178
Dublin 174
Bremen 170
Sterling 168
Lancaster 149
Bologna 147
Tokyo 137
Guangzhou 129
Phoenix 123
Naples 119
Florence 114
Boardman 110
Norwalk 110
Orem 110
Miami 106
Dulles 103
Palermo 102
Toronto 102
Detroit 97
Falls Church 94
Delhi 92
Turin 92
Istanbul 88
Mexico City 86
Bari 82
New Delhi 80
Da Nang 79
Denver 78
Warsaw 78
Montreal 77
Haiphong 75
Genoa 74
Catania 72
Munich 72
Verona 72
Nanjing 71
Brooklyn 69
Kansas City 69
Johannesburg 68
Belize City 67
Miano 66
Chennai 65
San Francisco 59
Belo Horizonte 56
Dong Ket 56
Jinan 56
Manchester 55
Kunming 53
Pittsburgh 52
Totale 76.746
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.837
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 953
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 781
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 761
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 687
Semeiotica dell'articolazione temporo-mandibolare 554
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 470
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 451
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 442
B-cells and mixed cryoglobulinemia 440
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 434
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 431
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 430
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 415
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 386
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 384
Thymus alterations and systemic sclerosis 383
Endocrine manifestations of hepatitis C virus infection. 381
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 378
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 374
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 373
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 372
Heart involvement and systemic sclerosis 368
Systemic sclerosis in childhood - Clinical and immunologic features of 153 patients in an international database 361
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 360
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 358
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 357
Current treatment of hepatitis C-associated rheumatic diseases. 354
Validation of the classification criteria for cryoglobulinaemic vasculitis 353
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 352
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 349
Cardiac Involvement in Systemic Vasculitis 349
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 348
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 348
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 348
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 346
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 345
Scleroderma digital ulcers complicated by infection with fecal pathogens. 344
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 344
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 342
Aortic pulse wave velocity measurement in systemic sclerosis patients. 342
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 342
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 339
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 337
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 336
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 334
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 333
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 332
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 332
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 329
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change 327
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 327
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 325
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis 325
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 324
Elevated Troponin Serum Levels in Adult Onset Still's Disease 324
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 324
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 323
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 321
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 321
L-Arginine in pregnant scleroderma patients 321
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 320
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 319
Associations between Systemic Sclerosis and Thyroid Diseases 319
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 316
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 316
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 313
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 312
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 312
Cytokines and HCV-related disorders 311
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 310
Non HCV-related mixed cryoglobulinemia 309
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 309
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 308
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 307
Platelet gel in the treatment of severe scleroderma skin ulcers. 307
The A, B, Cs of viral hepatitis in the biologic era. 306
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 305
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 304
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 304
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 302
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 299
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 299
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 297
HCV and cryoglobulinemic vasculitis. 296
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 296
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 296
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 294
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 293
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 291
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 291
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 290
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 289
GISEA: an Italian biological agents registry in rheumatology 287
Role of the HLA class II: HCV-related disorders 287
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 286
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. 285
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 285
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 285
Cardiovascular risk and prostanoids in systemic sclerosis 284
Totale 39.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 428.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 428.672
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021524 0 0 0 0 0 0 0 0 0 0 0 524
2021/20227.902 212 961 816 688 225 438 427 430 891 607 1.239 968
2022/20237.691 1.000 615 410 558 962 1.174 370 689 963 183 469 298
2023/20246.193 242 364 373 611 1.307 501 594 655 145 384 413 604
2024/202516.486 663 224 296 1.315 3.092 2.336 829 931 1.887 1.376 1.659 1.878
2025/202633.113 1.667 1.205 2.541 4.677 7.266 2.616 3.613 1.479 2.666 2.719 2.404 260
Totale 109.914